Context Therapeutics Inc
NASDAQ:CNTX
Cash Flow Statement
Cash Flow Statement
Context Therapeutics Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
7
|
5
|
(8)
|
(8)
|
(10)
|
(13)
|
(12)
|
(14)
|
(15)
|
(18)
|
(19)
|
(21)
|
(24)
|
(21)
|
(19)
|
(30)
|
(27)
|
(28)
|
(34)
|
(26)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(9)
|
(8)
|
4
|
4
|
4
|
4
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
15
|
16
|
16
|
16
|
2
|
|
| Change in Working Capital |
1
|
0
|
(1)
|
0
|
(2)
|
(2)
|
(1)
|
(2)
|
(0)
|
1
|
0
|
2
|
2
|
1
|
(1)
|
(2)
|
(3)
|
(3)
|
1
|
3
|
|
| Cash from Operating Activities |
(1)
N/A
|
(3)
-149%
|
(4)
-68%
|
(4)
+7%
|
(9)
-119%
|
(11)
-24%
|
(12)
-7%
|
(15)
-25%
|
(14)
+7%
|
(15)
-14%
|
(17)
-12%
|
(18)
-3%
|
(21)
-19%
|
(20)
+7%
|
(18)
+6%
|
(17)
+8%
|
(15)
+14%
|
(16)
-8%
|
(18)
-16%
|
(23)
-26%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
(15)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-16%
|
(0)
+86%
|
(1)
-1 250%
|
(1)
N/A
|
(1)
+7%
|
(1)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(15)
N/A
|
(15)
+2%
|
(15)
-2%
|
(15)
N/A
|
(0)
+100%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
4
|
6
|
5
|
58
|
55
|
53
|
53
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
0
|
15
|
15
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
95
|
95
|
95
|
95
|
0
|
(0)
|
|
| Cash from Financing Activities |
1
N/A
|
4
+261%
|
6
+39%
|
5
-22%
|
58
+1 192%
|
55
-5%
|
53
-4%
|
54
+2%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
95
N/A
|
95
+0%
|
109
+15%
|
109
0%
|
14
-87%
|
14
-1%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
2
+1 345%
|
1
-23%
|
0
-79%
|
49
+18 877%
|
44
-11%
|
42
-6%
|
39
-6%
|
(14)
N/A
|
(16)
-12%
|
(18)
-11%
|
(18)
+0%
|
(21)
-19%
|
(20)
+7%
|
76
N/A
|
63
-17%
|
80
+27%
|
78
-2%
|
(19)
N/A
|
(9)
+53%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(3)
-149%
|
(4)
-68%
|
(4)
+7%
|
(9)
-119%
|
(11)
-24%
|
(12)
-7%
|
(15)
-25%
|
(14)
+7%
|
(15)
-14%
|
(17)
-12%
|
(18)
-3%
|
(21)
-19%
|
(20)
+7%
|
(18)
+6%
|
(17)
+8%
|
(15)
+14%
|
(16)
-8%
|
(18)
-16%
|
(23)
-25%
|
|